Eastman Chemical Company EMN
- Market cap
- $7.6B
- P/E
- 17.3×
Follow EMN
Target Price Range
Analyst price targets
Free account| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 56.03 | 74.78 | 67.40 | 61.22 | 34.44 | 96.27 | 69.91 | 68.89 | 80.71 | 56.11 |
Analyst estimates 2026–2028 Powerpack |
Low Price
|
||
| 78.79 | 94.96 | 112.45 | 86.18 | 104.83 | 130.47 | 129.48 | 92.21 | 114.50 | 103.82 |
High Price
|
|||
| 14,000 | 14,000 | 14,500 | 14,500 | 14,500 | 14,000 | 14,500 | 14,000 | 14,000 | 13,000 |
Employees
|
|||
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Revenue/Emp
|
|||
| 9,008 | 9,549 | 10,151 | 9,273 | 8,473 | 10,476 | 10,580 | 9,210 | 9,382 | 8,752 |
Revenue
|
|||
| 26.17% | 24.75% | 24.42% | 24.09% | 23.31% | 23.86% | 20.20% | 22.38% | 24.41% | 21.07% |
Gross Margin
|
|||
| 1,049 | 1,289 | 1,310 | 902 | 530 | 1,082 | 977 | 1,087 | 1,078 | 568 |
EBT
|
|||
| 11.65% | 13.50% | 12.91% | 9.73% | 6.26% | 10.33% | 9.23% | 11.80% | 11.49% | 6.49% |
EBT Margin
|
|||
| 859 | 1,388 | 1,084 | 762 | 489 | 867 | 796 | 896 | 908 | 475 |
Net Income
|
|||
| 580 | 587 | 604 | 611 | 574 | 538 | 477 | 498 | 509 | 513 |
Depreciation
|
|||
| 61.15 | 65.95 | 71.89 | 67.49 | 62.53 | 77.66 | 85.67 | 77.66 | 80.39 | 76.30 |
Revenue/Sh
|
|||
| 5.88 | 10.18 | 7.65 | 5.52 | 3.53 | 6.35 | 6.42 | 7.54 | 7.75 | 4.14 |
Earnings/Sh
|
|||
| 9.40 | 11.44 | 10.93 | 10.95 | 10.74 | 12.00 | 7.89 | 11.59 | 11.03 | 8.46 |
Cash Flow/Sh
|
|||
| (3.97) | (4.39) | (3.70) | (3.14) | (2.92) | (4.28) | (4.95) | (6.98) | (5.13) | (4.76) |
Capex/Sh
|
|||
| 5.43 | 7.06 | 7.22 | 7.81 | 7.82 | 7.72 | 2.95 | 4.60 | 5.90 | 3.70 |
Free CF/Sh
|
|||
| 31.28 | 37.85 | 41.63 | 43.90 | 45.08 | 42.91 | 42.40 | 46.63 | 50.15 | 52.63 |
Book Value/Sh
|
|||
| 147 | 145 | 141 | 137 | 136 | 135 | 124 | 119 | 117 | 115 |
Shares
|
|||
| 12.91 | 9.24 | 9.58 | 14.38 | 28.49 | 18.92 | 12.91 | 11.85 | 11.77 | 15.42 |
PE Ratio
|
|||
| 1.24 | 1.43 | 1.02 | 1.17 | 1.60 | 1.56 | 0.96 | 1.15 | 1.14 | 0.84 |
PS Ratio
|
|||
| 2.43 | 2.49 | 1.76 | 1.81 | 2.22 | 2.82 | 1.94 | 1.92 | 1.82 | 1.21 |
PB Ratio
|
|||
| 1.92 | 2.05 | 1.58 | 1.76 | 2.16 | 1.93 | 1.29 | 1.56 | 1.53 | 1.25 |
EV/Sales
|
|||
| 21.64 | 19.18 | 15.71 | 15.19 | 17.27 | 19.47 | 37.57 | 26.30 | 20.91 | 25.84 |
EV/FCF
|
|||
| 1,385 | 1,657 | 1,543 | 1,504 | 1,455 | 1,619 | 975 | 1,374 | 1,287 | 970 |
Op' Cash Flow
|
|||
| (585) | (635) | (523) | (431) | (396) | (578) | (611) | (828) | (599) | (546) |
Capex
|
|||
| 800 | 1,022 | 1,020 | 1,073 | 1,059 | 1,041 | 364 | 546 | 688 | 424 |
FCF
|
|||
| 1,071 | 1,161 | 1,514 | 1,532 | 1,503 | 1,675 | 527 | 905 | 1,393 | 993 |
Working Cap'
|
|||
| 6,311 | 6,147 | 5,925 | 5,611 | 5,269 | 4,412 | 4,025 | 4,305 | 4,567 | 4,201 |
Total Debt
|
|||
| 6,130 | 5,956 | 5,699 | 5,407 | 4,705 | 3,953 | 3,532 | 3,757 | 3,730 | 3,635 |
Net Debt
|
|||
| 4,608 | 5,480 | 5,878 | 6,032 | 6,108 | 5,788 | 5,236 | 5,530 | 5,852 | 6,037 |
Sh' Equity
|
|||
| 5.50% | 8.80% | 6.75% | 4.74% | 2.98% | 5.42% | 5.25% | 6.10% | 6.06% | 3.15% |
ROA
|
|||
| 8.08% | 8.36% | 8.38% | 6.12% | 4.28% | 11.65% | 8.57% | 6.59% | 8.34% | 5.01% |
ROIC
|
|||
| 19.79% | 27.44% | 19.02% | 12.75% | 7.87% | 14.41% | 14.39% | 16.61% | 15.90% | 7.97% |
ROE
|
|||
Eastman Chemical Company peers in Specialty Chemicals
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| NEU NewMarket Corporation | $8.2B | 19.3× | Compare |
| AXTA Axalta Coating Systems Ltd. | $6.9B | 20.2× | Compare |
| ESI Element Solutions Inc. | $8.4B | 48.3× | Compare |
| WLK Westlake Corporation | $8.5B | 0.0× | Compare |
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| SOLS Solstice Advanced Materials Inc. | $9.0B | 26.2× | Compare |
| SSL Sasol Ltd. | $9.1B | 3.0× | Compare |
| SQM Sociedad Quimica y Minera S.A. | $9.7B | 12.1× | Compare |
| SXT Sensient Technologies Corporation | $5.5B | 34.7× | Compare |
Eastman Chemical Company (EMN) key facts
- Eastman Chemical Company (EMN) is a Specialty Chemicals company in the Basic Materials sector, listed on the New York Stock Exchange.
- Eastman Chemical Company’s revenue for fiscal 2025 (year ended December 2025) was $8.8 billion, down 6.71% from fiscal 2024.
- Net income was $475.0 million, or $4.14 per share (basic), a net margin of 5.42%.
- As of September 25, 2026, EMN traded at $66.97, a market capitalization of $7.6 billion.
- At that price the stock trades at 17.3× trailing-twelve-month earnings and 0.9× sales.
- Eastman Chemical Company pays an annual dividend of $3.16 per share, a yield of 3.95%, with a payout ratio of 52.9%.
- Return on equity was 7.97% and debt-to-equity 0.72.
Eastman Chemical Company (EMN) Latest News
29 Aug
Eastman Chemical (EMN) stock rebounds, renewing investor focus on its undervalued status. Stock rebound signals renewed attention to undervaluation that could influence near-term market sentiment and share performance.
7 Aug
Eastman Chemical (EMN) reported Q2 2026 financial results and outlook during its earnings call. Quarterly earnings updates deliver financial metrics that moderately shift near-term investor sentiment and valuation.
31 Jul
Eastman Chemical Q2 earnings call highlighted financial results including revenue, EPS, segment performance, cost management efforts, and updated guidance amid challenging market conditions. Q2 earnings details and guidance offer moderate insight into near-term financial trajectory and operational adjustments.
Eastman Chemical beat Q2 earnings expectations on higher sales volumes and increased pricing. Q2 earnings beat from volume and pricing gains indicates moderate short-term financial and market effects.
Eastman Chemical Company released Q2 2026 earnings results during its earnings call, covering revenue, earnings per share, segment performance, and forward guidance. Quarterly earnings calls typically provide financial updates that moderately influence near-term stock sentiment without altering long-term fundamentals.
30 Jul
Eastman Chemical Company released its second-quarter 2026 financial results. Quarterly earnings directly shape near-term stock valuation and forward guidance.
Eastman Chemical reported Q2 earnings with key metrics compared against analyst estimates. Q2 earnings metric comparisons can shift market views on financial performance.
22 Jun
Eastman Chemical Company acquires Jarylec dielectric fluids to expand its portfolio. Acquisition adds dielectric fluids capability with moderate growth potential in chemicals.
19 May
Eastman Chemical advances technology to convert plastic waste into valuable materials, opening a potential trillion-dollar market opportunity. Transformative recycling technology could significantly boost Eastman's long-term growth and market position.
9 May
Eastman Chemical reported soft earnings that disappointed on the surface, but underlying operational improvements, cost controls, and strategic progress paint a more optimistic picture for future performance. Soft earnings are counterbalanced by positive operational and strategic factors, creating moderate impact on financial performance and market sentiment.
4 May
International markets profoundly influence Eastman Chemical Company (EMN), with in-depth analysis guiding investor strategies amid global dynamics. International market dynamics moderately affect EMN's operations and competitive positioning without fundamental changes.
2 May
Eastman Chemical beat Q1 2026 earnings expectations, driven by strong Renew Platform momentum, prompting a valuation review amid positive outlook. Q1 2026 earnings beat and Renew Platform momentum indicate significant positive shifts in financial performance and strategic growth for EMN.
Eastman Chemical (EMN) reported strong revenue growth in Q1 2026 earnings call amid market challenges, highlighting robust performance. Strong Q1 2026 revenue growth amid market headwinds signals significant positive impact on EMN's financial trajectory and investor sentiment.
1 May
Eastman Chemical Company (EMN) released its Q1 2026 earnings call transcript detailing first-quarter financial results, management's outlook, and strategic updates. Q1 2026 earnings transcript discloses financial performance, guidance, and strategic insights that significantly influence investor sentiment and stock trajectory.
Eastman Chemical Company released Q1 earnings call highlights detailing financial results, strategic updates, and outlook. Q1 earnings highlights moderately affect financial performance and investor sentiment but are balanced by ongoing operations.
Eastman Chemical Company released Q1 2026 earnings call summary detailing financial results, segment performance, strategic initiatives, and outlook amid market challenges. Quarterly earnings summaries influence financial performance and investor sentiment moderately without fundamentally altering long-term trajectory.
Eastman Chemical (EMN) Q1 earnings beat estimates, but revenues missed due to lower year-over-year volumes. Earnings beat estimates despite revenue miss from lower volumes, creating moderately noticeable mixed impact on financial performance.
30 Apr
Eastman Chemical (EMN) Q1 earnings key metrics compared to Wall Street estimates. Q1 earnings metrics versus Wall Street estimates significantly influence EMN's stock price, investor sentiment, and short-term market performance.
Eastman Chemical (EMN) Q1 earnings surpassed analyst estimates. Q1 earnings beat signals strong financial performance, positively influencing investor sentiment and near-term stock trajectory.
Eastman Chemical Company announced first-quarter 2026 financial results. Quarterly earnings announcements significantly impact financial performance metrics, investor sentiment, and stock trajectory.
23 Apr
Analysts predict Eastman Chemical (EMN) will report declining earnings, urging focus on key metrics and potential surprises in the upcoming release. Forecasted earnings decline expected to moderately affect EMN's financial results and investor sentiment.
22 Apr
JPMorgan upgrades input cost outlook for Eastman Chemical (EMN), prompting analysis on whether it strengthens the bull case for EMN's earnings power. JPMorgan's input cost upgrade indicates potential margin expansion for EMN, moderately influencing earnings outlook and market sentiment.
2 Apr
Eastman Chemical (EMN) emerges as the overlooked non-defense winner for investors amid supply shocks from the Iran war, benefiting from disrupted petrochemical supplies while defense stocks dominate attention. Iran war supply shock elevates EMN's strategic position in chemicals, likely sparking major investor reallocation and performance uplift.
2 Mar
Eastman Chemical Company issued new senior notes, reshaping its debt profile and redirecting investor focus toward improved financial health and strategic positioning. Issuance of new senior notes significantly refines debt structure, bolstering balance sheet strength and investor confidence.
20 Feb
Analysts detect signs of commodity prices bottoming out after Eastman Chemical Company (EMN) released Q4 results. Analyst observations of commodity bottoming post-Q4 results signal moderately improved financial performance and market sentiment for EMN.
12 Feb
Eastman Chemical Company (EMN) faces challenges as SPSM falls short of expectations, impacting its small-cap promise. The company's performance is under scrutiny as it navigates market dynamics and operational hurdles. Investors are concerned about the implications for EMN's growth trajectory and competitive positioning in the industry. SPSM's underperformance may moderately influence Eastman Chemical's market sentiment and operational aspects.
5 Feb
RBC Capital has raised its price target for Eastman Chemical Company (EMN) from $70 to $79, reflecting a positive outlook on the company's performance and market position. The price target increase indicates a moderately noticeable influence on investor sentiment and potential financial performance.
4 Feb
Eastman Chemical Company is implementing cost-cutting measures and executing its ETP (Enhanced Technology Platform) strategy to improve its investment narrative. These initiatives aim to enhance operational efficiency and drive profitability, positioning the company for better market performance amidst evolving industry dynamics. Cost cuts and strategic execution are likely to significantly impact Eastman's future performance and investor sentiment.
2 Feb
Eastman Chemical Company (EMN) is increasingly reliant on international sales, which has become a significant aspect of its growth strategy. The company is focusing on expanding its global footprint to mitigate risks associated with domestic market fluctuations. Investors should be aware of the potential benefits and challenges that come with this international reliance, including currency fluctuations and geopolitical factors that could impact sales performance. Understanding these dynamics is crucial for assessing EMN's future market position and financial health. International sales reliance may moderately influence EMN's financial performance and competitive positioning.
30 Jan
Eastman Chemical Company reported its Q4 earnings, highlighting strong performance driven by increased demand in key markets. The company emphasized its focus on innovation and sustainability, with plans for new product launches and investments in technology. Management provided insights into operational efficiencies and cost management strategies that contributed to improved margins. Future outlook remains positive, with expectations for continued growth in various segments despite potential market challenges. Significant strategic moves and product innovations are expected to influence future performance and investor sentiment.